Application of Point-of-care Ultrasound in Rapid Assessment of Cardiac Arrest Patients

Sponsor
Zhongnan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05859516
Collaborator
(none)
50
1
16.9
3

Study Details

Study Description

Brief Summary

To quickly assess the patient's cardiac function and structure through ultrasound

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasound

Detailed Description

Monitor the peripheral arterial pulse and flow velocity, monitor the patient's lung and diaphragm muscle movement, monitor the patient's optic nerve sheath and cerebral blood flow, observe the morphology and blood flow of the liver and kidney and other parenchymal organs, Comprehensive evaluation of patient resuscitation quality.

For patients with cardiac arrest undergoing Cardio Pulmonary Resuscitation (CPR), the above monitoring was completed by ultrasound, and compared with the parameters obtained by end-expiratory carbon dioxide (ETCO2) and compression feedback device, to evaluate the feasibility of ultrasound to evaluate the quality of CPR. After the reliability evaluation was completed, parameters were further used to guide CPR quality improvement through ultrasound, end-expiratory carbon dioxide (ETCO2), and compression feedback device.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Application of Point-of-care Ultrasound in Rapid Assessment of Cardiac Arrest Patients
Actual Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Jan 31, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound

Diagnostic Test: Ultrasound
Every time checking pulse, evaluate the carotid artery compressibility and blood flow of peripheral arteries by ultrasound,compared with EtCO2.

Outcome Measures

Primary Outcome Measures

  1. The correlation between return of spontaneous circulation rate and peripheral blood flow through study completion, an average of 1 hour. [through study completion, an average of 1 hour.]

    For patients with cardiac arrest undergoing CPR, Peripheral arterial blood flow monitoring was completed by ultrasound, and compared with treturn of spontaneous circulation rate . Bilateral carotid blood flow velocity: Peak systolic velocity, PSV, cm/s End diastolic velocity, EDV,cm/s Resistance index, RI Pulsatility index, PI Bilateral femoral artery blood flow velocity 1) Peak systolic velocity, PSV, cm/s 2) End diastolic velocity, EDV,cm/s 3) Resistance index, RI 4) Pulsatility index, P

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Voluntarily participate and sign a written informed consent;

  • Male or female above 18;

  • Patients who are sent to the emergency room of our hospital with symptoms of "cardiopulmonary resuscitation";

Exclusion Criteria:
  • There is trauma in the ultrasound examination site and it is not suitable for ultrasound examination;

  • Entering the emergency room without vital signs for more than 30 minutes;

  • The appearance of corpse corpses;

  • There is life-threatening and irreversible damage;

  • Other investigators consider it inappropriate and the patient or family member refuses;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongnan Hospital of Wuhan University Wuhan Hubei China 430000

Sponsors and Collaborators

  • Zhongnan Hospital

Investigators

  • Principal Investigator: Jian Xia, Dr., Wuhan University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Zhongnan Hospital
ClinicalTrials.gov Identifier:
NCT05859516
Other Study ID Numbers:
  • 2022003
First Posted:
May 16, 2023
Last Update Posted:
May 16, 2023
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhongnan Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023